AAAAAA
Results: 76-100/230
Authors:
MEYER HP
LEGEMATE DA
VANDENBROM W
ROTHUIZEN J
Citation: Hp. Meyer et al., IMPROVEMENT OF CHRONIC HEPATIC-ENCEPHALOPATHY IN DOGS BY THE BENZODIAZEPINE-RECEPTOR PARTIAL INVERSE AGONIST SARMAZENIL, BUT NOT BY THE ANTAGONIST FLUMAZENIL, Metabolic brain disease, 13(3), 1998, pp. 241-251
Authors:
NEWFRY GA
JONES KJ
Citation: Ga. Newfry et Kj. Jones, DIFFERENTIAL-EFFECTS OF FACIAL-NERVE TRANSECTION ON HEAT-SHOCK-PROTEIN-70 EXPRESSION IN THE DEVELOPING AND ADULT HAMSTER FACIAL NUCLEUS, Metabolic brain disease, 13(3), 1998, pp. 253-257
Authors:
DESJARDINS P
LEDOUX S
Citation: P. Desjardins et S. Ledoux, THE ROLE OF APOPTOSIS IN NEURODEGENERATIVE DISEASES, Metabolic brain disease, 13(2), 1998, pp. 79-96
Authors:
HAZELL AS
TODD KG
BUTTERWORTH RF
Citation: As. Hazell et al., MECHANISMS OF NEURONAL CELL-DEATH IN WERNICKES ENCEPHALOPATHY, Metabolic brain disease, 13(2), 1998, pp. 97-122
Authors:
MARCUS CD
TAYLORROBINSON SD
SARGENTONI J
AINSWORTH JG
FRIZE G
EASTERBROOK PJ
SHAUNAK S
BRYANT DJ
Citation: Cd. Marcus et al., H-1 MR SPECTROSCOPY OF THE BRAIN IN HIV-1-SEROPOSITIVE SUBJECTS - EVIDENCE FOR DIFFUSE METABOLIC ABNORMALITIES, Metabolic brain disease, 13(2), 1998, pp. 123-136
Authors:
ALEXANDER B
ASLAM M
NOBIN A
BENJAMIN IS
Citation: B. Alexander et al., DIFFERENTIATION BETWEEN THE EFFECTS OF UNPROCESSED PORTAL BLOOD AND REDUCED LIVER-FUNCTION ON BRAIN INDOLE AMINE METABOLISM IN THE PORTACAVAL SHUNTED RAT, Metabolic brain disease, 13(2), 1998, pp. 137-146
Authors:
ROSE C
MICHALAK A
PANNUNZIO P
THERRIEN G
QUACK G
KIRCHEIS G
BUTTERWORTH RF
Citation: C. Rose et al., L-ORNITHINE-L-ASPARTATE IN EXPERIMENTAL PORTAL-SYSTEMIC ENCEPHALOPATHY - THERAPEUTIC EFFICACY AND MECHANISM OF ACTION, Metabolic brain disease, 13(2), 1998, pp. 147-157
Authors:
AMODIO P
MARCHETTI P
DELPICCOLO F
RIZZO C
IEMMOLO RM
CAREGARO L
GERUNDA G
GATTA A
Citation: P. Amodio et al., STUDY ON THE STERNBERG PARADIGM IN CIRRHOTIC-PATIENTS WITHOUT OVERT HEPATIC-ENCEPHALOPATHY, Metabolic brain disease, 13(2), 1998, pp. 159-172
Authors:
HAGHIGHAT N
MCCANDLESS DW
Citation: N. Haghighat et Dw. Mccandless, EFFECT OF AMMONIUM-CHLORIDE ON ENERGY-METABOLISM OF ASTROCYTES AND C6-GLIOMA CELLS IN-VITRO (VOL 12, PG 287, 1997), Metabolic brain disease, 13(2), 1998, pp. 173-173
Authors:
SHARMA BK
KUMAR K
Citation: Bk. Sharma et K. Kumar, ROLE OF PROINFLAMMATORY CYTOKINES IN CEREBRAL-ISCHEMIA - A REVIEW, Metabolic brain disease, 13(1), 1998, pp. 1-8
Authors:
ARAKI T
KATO H
SHUTO K
ITOYAMA Y
Citation: T. Araki et al., POSTISCHEMIC ALTERATIONS IN [H-3]FK506 BINDING IN THE GERBIL AND RAT BRAINS, Metabolic brain disease, 13(1), 1998, pp. 9-19
Authors:
PATRINI C
NAUTI A
RINDI G
Citation: C. Patrini et al., THIAMINE PYROPHOSPHATE-DEPENDENT AND THIAMINE METABOLIZING ENZYMES INTHE DEAFFERENTED CEREBELLUM AND IN THE INTACT CEREBRAL-CORTEX OF RAT, Metabolic brain disease, 13(1), 1998, pp. 21-27
Authors:
KOSENKO E
KAMINSKY Y
LOPATA O
MURAVYOV N
KAMINSKY A
HERMENEGILDO C
FELIPO V
Citation: E. Kosenko et al., NITROARGININE, AN INHIBITOR OF NITRIC-OXIDE SYNTHASE, PREVENTS CHANGES IN SUPEROXIDE RADICAL AND ANTIOXIDANT ENZYMES INDUCED BY AMMONIA INTOXICATION, Metabolic brain disease, 13(1), 1998, pp. 29-41
Authors:
GOLD M
HAUSER RA
CHEN MF
Citation: M. Gold et al., PLASMA THIAMINE-DEFICIENCY ASSOCIATED WITH ALZHEIMERS-DISEASE BUT NOTPARKINSONS-DISEASE, Metabolic brain disease, 13(1), 1998, pp. 43-53
Authors:
PASCHEN W
GISSEL C
LINDEN T
DOUTHEIL J
Citation: W. Paschen et al., ERP72 EXPRESSION ACTIVATED BY TRANSIENT CEREBRAL-ISCHEMIA OR DISTURBANCE OF NEURONAL ENDOPLASMIC-RETICULUM CALCIUM STORES, Metabolic brain disease, 13(1), 1998, pp. 55-68
Authors:
AUDET RM
BUTTERWORTH RF
Citation: Rm. Audet et Rf. Butterworth, PORTACAVAL ANASTOMOSIS RESULTS IN MORE WIDESPREAD ALTERATIONS OF CEREBRAL METABOLISM IN OLD VERSUS YOUNG-ADULT RATS - IMPLICATIONS FOR POST-SHUNT ENCEPHALOPATHY, Metabolic brain disease, 13(1), 1998, pp. 69-78
Authors:
Weissenborn, K
Kolbe, H
Citation: K. Weissenborn et H. Kolbe, The basal ganglia and portal-systemic encephalopathy, METAB BRAIN, 13(4), 1998, pp. 261-272
Authors:
Morgan, MY
Citation: My. Morgan, Cerebral magnetic resonance imaging in patients with chronic liver disease, METAB BRAIN, 13(4), 1998, pp. 273-290
Authors:
Kostler, H
Citation: H. Kostler, Proton magnetic resonance spectroscopy in portal-systemic encephalopathy, METAB BRAIN, 13(4), 1998, pp. 291-301
Authors:
Lockwood, AH
Citation: Ah. Lockwood, Positron emission tomography in the study of hepatic encephalopathy, METAB BRAIN, 13(4), 1998, pp. 303-309
Authors:
Layrargues, GP
Rose, C
Spahr, L
Zayed, J
Normandin, L
Butterworth, RF
Citation: Gp. Layrargues et al., Role of manganese in the pathogenesis of portal-systemic encephalopathy, METAB BRAIN, 13(4), 1998, pp. 311-317
Authors:
Norenberg, MD
Citation: Md. Norenberg, Astroglial dysfunction in hepatic encephalopathy, METAB BRAIN, 13(4), 1998, pp. 319-335
Authors:
Butterworth, RF
Citation: Rf. Butterworth, Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy, METAB BRAIN, 13(4), 1998, pp. 337-349
Authors:
Jones, EA
Basile, AS
Citation: Ea. Jones et As. Basile, Does ammonia contribute to increased GABA-ergic neurotransmission in liverfailure?, METAB BRAIN, 13(4), 1998, pp. 351-360
Authors:
Schomerus, H
Hamster, W
Citation: H. Schomerus et W. Hamster, Neuropsychological aspects of portal-systemic encephalopathy, METAB BRAIN, 13(4), 1998, pp. 361-377